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Case Presentation:
Drug Induced T-Cell Dyscrasia Mimicking Granulomatous Mycosis Fungoides
Discussion:
T-cell dyscrasia is a term used to encompass a group of disorders that often present with a 
cutaneous infiltrate, exhibiting cytologic and histopathological atypia, which may be associated 
with a clonal T-cell population. These disorders may mimick other entities both clinically and 
histopathologically, such as mycosis fungoides (MF) or cutaneous T-cell lymphoma. Clinical 
characteristics of drug-induced MF-like lesions can be quite variable, ranging from discreet 
papules, plaques or nodules to a more diffuse, maculopapular eruption or rarely, erythroderma. 
Descriptions of this disease have appeared in the literature under various terms, such as drug-
associated pseudolymphoma and drug-associated reversible T-cell dyscrasia. The defining 
characteristics of such cases are that of an atypical lymphocytic cutaneous proliferation with 
findings similar to MF in their histopathological, phenotypic and molecular profiles. By definition, 
the eruption may begin weeks to years after initiation of a medication with complete resolution 
upon its discontinuation and worsening or recurrence with medication re-challenge. Medications 
reported in the literature that cause similar eruptions include: antihistamines, anticonvulsants, 
antipsychotics, serotonin reuptake inhibitors, penicillin, dapsone, nitrofurantoin, vancomycin, 
rifampin, beta-blockers, calcium channel blockers, angiotensin-converting enzyme inhibitors 
and many more. Contrarily, over the counter medications and supplements, as in our patient’s 
case, have rarely been reported as causative agents. The proposed pathogenesis of this entity 
is that of antigenic stimulation from the medication resulting in aberrant T-cell proliferation. 
Histopathological findings are variable and may simulate both interstitial granulomatous disease 
as well as MF, as reported by Magro et al. Features may include: superficial and mid dermal 
atypical lymphocytic associated with a palisading histiocytic infiltrate, epidermotropism, elevated 
CD4:CD8 ratio and loss of CD7. Cases have been reported in association with monoclonal T-cell 
populations in both biopsy specimens and peripheral blood, however the majority are polyclonal. 
Patients are reported to have complete resolution of their skin findings in as early as one to 
twelve weeks of medication discontinuation. In many cases no recurrence has been reported in 
up to three years, according to one study. These patients should avoid the inciting medication 
and should be followed to ensure long-term resolution of their disease. It is unknown if the 
antigenic stimulation predisposes them to the development of lymphoma in the future.
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Patient: 47 year-old Indian male. 
History of Present Illness: The patient presented with an 
eight-month history of pruritic papules on the arms and legs, which gradually 
spread to involve the face. The lesions were not responsive to topical 
corticosteroids alone. He denied systemic symptoms or new medications. 
However, he admitted to beginning new hair loss regimen, with an oral 
dietary supplement (containing vitamins B3, D and E, biotin, saw palmetto 
and nettle root). The patient was instructed to discontinue this supplement 
upon presentation and had complete clearance of his rash within two weeks. 
Medical/Surgical History: Nephrolithiasis, tinea pedis
Family History: Negative for skin cancer or hematological 
malignancy
Medications: Hair Revitalizing Complex, halobetasol propionate 
0.05% ointment, econazole nitrate 1% cream, miconazole topical powder 
Previous Medications: Fluoruracil 5%, doxycycline, clobetasol 
proprionate 0.05% cream
Current Treatment: Halobetasol propionate 0.05% ointment, 
CeraVe moisturizing cream
Physical Examination: The patient presents with multiple 
scattered, pink to violaceous papules involving the glabella, eyelids, 
periorbital areas, arms and legs. There is no palpable lymphadenopathy.
Laboratory Data: (08/25/2015) T-cell receptor (TCR) gamma gene 
rearrangement by PCR positive. 
Biopsy: Advanced Dermatology Associates, LTD (AD15-09941, 
08/25/2015) Right temple: “Mycosis fungoides. There are nodular 
lymphohistiocytic infiltrates in the superficial half of the dermis that, on 
multiple sections, appear to be perifollicular. Lymphocytes are also scattered 
and clustered in the epidermis, and within follicular epithelium. IHC stains 
demonstrate a significant loss of CD7 positivity overall (with less than 10% 
of cells staining), when compared with CD2, CD3, and CD5. Intraepidermal 
lymphocytes are entirely CD7-. CD4 and CD8 stains demonstrate an 
overall helper:suppressor ratio of greater than 10:1, while intraepidermal 
lymphocytes are almost entirely CD4+/CD8-. CD45RB and CD45RO 
highlight all lymphocytes in a roughly equal fashion. The immunostains 
also demonstrate intraepidermal lymphocytes to be conspicuously aligned 
in the basal layer across the surface and also down the sides of follicular 
epithelium. 
Diagnosis: Drug Induced T-Cell Dyscrasia Mimicking 
Granulomatous Mycosis Fungoides.
Follow-up: The patient was instructed to avoid the dietary supplement 
and followed closely. He had no evidence of recurrence at six months follow-up. 
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Figures 1-3: Scattered, pink to violaceous papules located on the face, back and flank
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Figures 4-6: Punch biopsy of the right temple demonstrating a nodular, lymphohistiocytic infiltrate in the 
superficial dermis with lymphocytes perifollicularly, tagging the basal layer, and within epidermis
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